Tilray, Inc., wholly owned subsidiary of private company Privateer Holdings, Inc., has officially announced this week pricing on its NADAQ initial public offering of the company’s stock.
Tilray is a global medicinal cannabis researcher, cultivator, processor, and distributer of finished product. The company prides itself on its vertically integrated business model and scientifically driven manufacturing techniques. The company sells a number of different products that include THC, CBD, and a blend of both cannabinoids in the form of cannabis flower and other extracts.
The company will offering 9,000,000 shares of Class 2 common stock. 6,524,000 will be sold in the U.S. and 2,476,000 shares to be sold in Canada at $17.oo a share. Based on the exchange rate between the two countries Tilray expects the IPO to raise the company a total of US$153,000,000.00
Tilray will begin trading on the Nasdaq Global Market Exchange under the ticker symbol TLRY. The company has successfully completed its registration statement on Form S-1 and the SEC has approved the offering. Cowen and BMO Capital Markets are acting jointly as book-runners for the IPO.